EE+ POEM Archive
SGLT2 inhibitors = little effect on glycemic control or all-cause mortality, but decrease CV deaths in older adults with T2DM plus heart failure
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "SGLT2 Inhibitors = Little Effect On Glycemic Control or All-cause Mortality, but Decrease CV Deaths in Older Adults With T2DM Plus Heart Failure." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377095/all/SGLT2_inhibitors_=_little_effect_on_glycemic_control_or_all_cause_mortality__but_decrease_CV_deaths_in_older_adults_with_T2DM_plus_heart_failure.
SGLT2 inhibitors = little effect on glycemic control or all-cause mortality, but decrease CV deaths in older adults with T2DM plus heart failure. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377095/all/SGLT2_inhibitors_=_little_effect_on_glycemic_control_or_all_cause_mortality__but_decrease_CV_deaths_in_older_adults_with_T2DM_plus_heart_failure. Accessed July 27, 2024.
SGLT2 inhibitors = little effect on glycemic control or all-cause mortality, but decrease CV deaths in older adults with T2DM plus heart failure. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377095/all/SGLT2_inhibitors_=_little_effect_on_glycemic_control_or_all_cause_mortality__but_decrease_CV_deaths_in_older_adults_with_T2DM_plus_heart_failure
SGLT2 Inhibitors = Little Effect On Glycemic Control or All-cause Mortality, but Decrease CV Deaths in Older Adults With T2DM Plus Heart Failure [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 July 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377095/all/SGLT2_inhibitors_=_little_effect_on_glycemic_control_or_all_cause_mortality__but_decrease_CV_deaths_in_older_adults_with_T2DM_plus_heart_failure.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - SGLT2 inhibitors = little effect on glycemic control or all-cause mortality, but decrease CV deaths in older adults with T2DM plus heart failure
ID - 3377095
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377095/all/SGLT2_inhibitors_=_little_effect_on_glycemic_control_or_all_cause_mortality__but_decrease_CV_deaths_in_older_adults_with_T2DM_plus_heart_failure
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
